Medical management of melanoma
- 30 April 2003
- journal article
- review article
- Published by Elsevier in Surgical Clinics of North America
- Vol. 83 (2) , 283-322
- https://doi.org/10.1016/s0039-6109(02)00187-1
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Results of a prospective randomized trial using DTIC and interferon as adjuvant therapy for stage I malignant melanomaEuropean Journal of Surgical Oncology, 1995
- Long-term adjuvant immunotherapy in stage I high risk malignant melanoma, comparing two BCG preparations versus non-treatment in a randomised multicentre study (EORTC protocol 18781)European Journal Of Cancer, 1993
- High-Dose Cisplatin and Dacarbazine in the treatment of Metastatic MelanomaJNCI Journal of the National Cancer Institute, 1990
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- Hematologic Remission and Cytogenetic Improvement Induced by Recombinant Human Interferon AlphaAin Chronic Myelogenous LeukemiaNew England Journal of Medicine, 1986
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985
- Treatment of Advanced Non-Hodgkin's Lymphoma with Recombinant Leukocyte a InterferonNew England Journal of Medicine, 1984
- Alpha Interferon for Induction of Remission in Hairy-Cell LeukemiaNew England Journal of Medicine, 1984
- Vitiligo in patients with metastatic melanoma: A good prognostic signJournal of the American Academy of Dermatology, 1983
- A Randomized Trial of Adjuvant Chemotherapy and Immunotherapy in Cutaneous MelanomaNew England Journal of Medicine, 1982